Literature DB >> 17172578

Severe chorea with positive anti-basal ganglia antibodies after herpesencephalitis.

I Marschitz, S Rödl, U Gruber-Sedlmayr, A Church, G Giovannoni, G Zobel, C J Mache, J Raith, B Plecko.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17172578      PMCID： PMC2117805          DOI： 10.1136/jnnp.2006.090555

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

1.  Long term neurological outcome of herpes encephalitis.

Authors:  E Lahat; J Barr; G Barkai; G Paret; N Brand; A Barzilai
Journal:  Arch Dis Child       Date:  1999-01       Impact factor: 3.791

Review 2.  [Acute disseminated encephalomyelitis. Pathogenesis, diagnosis, treatment, and prognosis].

Authors:  O Stüve; S Nessler; H P Hartung; B Hemmer; H Wiendl; B C Kieseier
Journal:  Nervenarzt       Date:  2005-06       Impact factor: 1.214

3.  Anti-basal ganglia antibodies: a possible diagnostic utility in idiopathic movement disorders?

Authors:  A J Church; R C Dale; G Giovannoni
Journal:  Arch Dis Child       Date:  2004-07       Impact factor: 3.791

4.  Relapse of herpes simplex encephalitis.

Authors:  M A Barthez-Carpentier; F Rozenberg; E Dussaix; P Lebon; A Goudeau; C Billard; M Tardieu
Journal:  J Child Neurol       Date:  1995-09       Impact factor: 1.987
  4 in total
  1 in total

1.  Clinical Neuropathology practice guide 4-2013: post-herpes simplex encephalitis: N-methyl-Daspartate receptor antibodies are part of the problem.

Authors:  Romana Höftberger; Thaís Armangue; Frank Leypoldt; Francesc Graus; Josep Dalmau
Journal:  Clin Neuropathol       Date:  2013 Jul-Aug       Impact factor: 1.368
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.